# The FIGHT-RP1 Study

> **NCT03063021** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 30 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DRUG:** N-Acetyl Cysteine (NAC)

## Key facts

- **NCT ID:** NCT03063021
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2019-02-11
- **Final completion:** 2019-02-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063021, "The FIGHT-RP1 Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03063021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*